Insider Purchases: Inside the Buy

Tag: Specialty Chemicals

Illustration of a modern chemical manufacturing facility with molecular structures blending into financial charts as a CEO purchases company stock ahead of Huntsman's proposed $12.5 billion merger with Olin, symbolizing long-term value investing.

🧪 Huntsman (HUN): CEO Buys $981K as Wall Street Overlooks a $12 Billion Chemical Merger

Huntsman isn't simply a cyclical chemical company anymore. Between repeated insider buying, a transformational $12.5 billion merger with Olin, trading at just 0.64x book value and more than $400 million in projected synergies, investors may be looking at one of the market's more intriguing industrial turnaround opportunities.

Read entire article

Tags: AQR Capital, buy or sell HUN, Chemicals, Contrarian Investment, Deep Value, Dividend Stocks, featured-insiders, FUNanc1al, FunStock Index, hub-insiders, HUN, Huntsman, Industrial Stocks, Industrials, Insider Buying, InsiderBuying, Investing, Merger Arbitrage, MergerOfEquals, NYSE, Olin, OlinCorporation, OlinHuntsman, OLN, Peter Huntsman, PeterHuntsman, risks buying HUN, Specialty Chemicals, Stocks, Turnaround, Turnaround Stocks, Value Investing, ValueInvesting, Vanguard, Wall Street, why buy HUN